About Richard Knight

Dr Richard Knight PhD, ERT. A co-founder of ApconiX, Richard is an expert toxicologist with more than 20 years of drug development experience gained in AstraZeneca, where he was part of the Drug Safety and Oncology Leadership Teams. Richard has worked on projects in multiple therapy areas involving small molecules, biologics, proteins and oligonucleotides. He has an in-depth understanding of drug discovery and drug development and has been directly involved in bringing over 35 new candidate drugs to clinical trials and 6 to marketing approval. He uses his extensive experience to bring an innovative, science-led and pragmatic approach to the design and delivery of nonclinical safety programmes.

ApconiX Welcomes Joanne Wilson

ApconiX Welcomes Joanne Wilson ApconiX is delighted to welcome Joanne Wilson who joins as a Project Manager and will be working with Dr Richard Knight. With over 20 years’ experience as a DMPK scientist and project manager at AstraZeneca, Jo has led cross-functional teams and driven the efficient development [...]

By |2023-08-29T11:35:45+01:00August 29th, 2023|Company News, Careers|Comments Off on ApconiX Welcomes Joanne Wilson

ApconiX Welcomes Stacey Owen

ApconiX Welcomes Stacey Owen ApconiX is delighted to welcome Stacey Owen who joins the Project Management team and will be working with Dr Richard Knight. Stacey has considerable business development experience and will also be supporting Dr Laurence Bishop, our Head of Business Development. Career Stacey graduated from Cardiff [...]

By |2023-08-29T11:35:04+01:00August 29th, 2023|Company News, Careers|Comments Off on ApconiX Welcomes Stacey Owen

ApconiX Welcomes Maxine Xodo-Rose

ApconiX Welcomes Maxine Xodo-Rose ApconiX is delighted to welcome Maxine Xodo-Rose to ApconiX as a Finance & Admin Assistant. Maxine has returned to work after a short career break to look after a young family and will be working with Louise Lake. Career Maxine graduated from the University of [...]

By |2023-03-15T16:13:17+00:00March 15th, 2023|Company News, Careers|Comments Off on ApconiX Welcomes Maxine Xodo-Rose

ApconiX Welcomes Sarah Pass

ApconiX Welcomes Sarah Pass ApconiX is delighted to welcome Sarah Pass who joins the team of nonclinical DMPK experts and will be working with Dr Richard Knight.  With a career in both industry and contract research, Sarah is an experienced drug metabolism and pharmacokinetics (DMPK) scientist with experience of [...]

By |2023-02-23T11:16:05+00:00December 6th, 2022|Company News, Toxicology, Careers|Comments Off on ApconiX Welcomes Sarah Pass

Lean Life Science and Cancer Research UK Launch the Oncology Development Programme (ODP2) to Accelerate Development of High Impact Novel Cancer Innovations

Lean Life Science and Cancer Research UK Launch the Oncology Development Programme (ODP2) to Accelerate Development of High Impact Novel Cancer Innovations ApconiX is very excited to be part of Oncology Development Programme2 (ODP2) the latest Development Programme launched on the 21st of November at Alderley Park focused on [...]

By |2022-11-29T09:22:45+00:00November 28th, 2022|Company News|Comments Off on Lean Life Science and Cancer Research UK Launch the Oncology Development Programme (ODP2) to Accelerate Development of High Impact Novel Cancer Innovations

ApconiX Welcomes Dr Amy Shepherd

ApconiX Welcomes Dr Amy Shepherd ApconiX is delighted to welcome Dr Amy Shepherd who joins the team of nonclinical safety experts and will be working with Dr Richard Knight. Amy is an experienced immunologist having worked for over 10 years in nonclinical and clinical safety program design with both [...]

By |2022-11-22T13:01:59+00:00October 8th, 2022|Company News, Toxicology, Careers|Comments Off on ApconiX Welcomes Dr Amy Shepherd

ApconiX Welcomes Scott Hackford

ApconiX Welcomes Scott Hackford ApconiX is delighted to welcome Scott Hackford who joins the team of nonclinical safety experts and will be working with Dr Richard Knight. Scott has over 12 years’ experience in a contract research organisation as a study director and lead toxicologist designing, conducting, and reporting [...]

By |2022-11-22T13:06:52+00:00October 1st, 2022|Company News, Toxicology, Careers|Comments Off on ApconiX Welcomes Scott Hackford

ApconiX Welcomes Dr Kerry Illston

ApconiX Welcomes Dr Kerry Illston ApconiX is delighted to welcome Dr Kerry Illston who joins the team of nonclinical safety experts and will be working with Dr Richard Knight. Kerry is an experienced Project Manager with over 25 years’ experience in molecular toxicology, new target identification/validation and nonclinical safety [...]

By |2022-11-22T13:09:36+00:00September 23rd, 2022|Company News, Toxicology, Careers|Comments Off on ApconiX Welcomes Dr Kerry Illston

Queen’s Award Celebration

Queen's Award Celebration On Tuesday the 6th of September Lady Redmond, Lord Lieutenant of Cheshire came to Alderley Park to present ApconiX with the Queen’s Award for Enterprise in recognition of excellence in international trade.  Lady Redmond, accompanied by Sir Philip Redmond, presented the certificate to the directors and co-founders Dr Richard Knight, [...]

By |2022-09-28T11:44:16+01:00September 21st, 2022|Company News|Comments Off on Queen’s Award Celebration
Go to Top